Dhruv Kumar

InstitutionAmity University Uttar Pradesh
AddressIndia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in January 2021
    All Publications
    Bar chart showing 32 publications over 14 distinct years, with a maximum of 6 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Jeyaraman M, Muthu S, Bapat A, Jain R, Sushmitha ES, Gulati A, Channaiah Anudeep T, Dilip SJ, Jha NK, Kumar D, Kesari KK, Ojha S, Dholpuria S, Gupta G, Dureja H, Chellappan DK, Singh SK, Dua K, Jha SK. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul; 7(7):e07635. PMID: 34312598.
      Citations: 1     
    2. Sharma PP, Kumar S, Srivastava S, Srivastava M, Jee B, Gorobets NY, Kumar D, Kumar M, Asthana S, Zhang P, Zoltner M, Rathi B. Computational study of novel inhibitory molecule, 1-(4-((2S,3S)-3-amino-2-hydroxy-4-phenylbutyl)piperazin-1-yl)-3-phenylurea, with high potential to competitively block ATP binding to the RNA dependent RNA polymerase of SARS-CoV-2 virus. J Biomol Struct Dyn. 2021 Jun 21; 1-19. PMID: 34151735.
      Citations:    Fields:    
    3. Chandel V, Tripathi G, Nayar SA, Rathi B, Kumar A, Kumar D. In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2. J Biomol Struct Dyn. 2021 May 03; 1-16. PMID: 33939590.
      Citations:    Fields:    
    4. Mathur A, Raj S, Jha NK, Jha SK, Rathi B, Kumar D. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2. 3 Biotech. 2021 May; 11(5):236. PMID: 33936927.
      Citations:    
    5. Roychoudhury S, Das A, Jha NK, Kesari KK, Roychoudhury S, Jha SK, Kosgi R, Choudhury AP, Lukac N, Madhu NR, Kumar D, Slama P. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health. Open Biol. 2021 01; 11(1):200347. PMID: 33465325.
      Citations: 5     Fields:    Translation:HumansCells
    6. Jha NK, Ojha S, Jha SK, Dureja H, Singh SK, Shukla SD, Chellappan DK, Gupta G, Bhardwaj S, Kumar N, Jeyaraman M, Jain R, Muthu S, Kar R, Kumar D, Goswami VK, Ruokolainen J, Kesari KK, Singh SK, Dua K. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. J Mol Neurosci. 2021 Nov; 71(11):2192-2209. PMID: 33464535.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    7. Satyam R, Jha NK, Kar R, Jha SK, Sharma A, Kumar D, Nand P, Ruokolainen J, Kesari KK, Kamal MA. Deciphering the SSR incidences across viral members of Coronaviridae family. Chem Biol Interact. 2020 Nov 01; 331:109226. PMID: 32971122.
      Citations: 3     Fields:    Translation:HumansCells
    8. Chandel V, Sharma PP, Raj S, Choudhari R, Rathi B, Kumar D. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2. J Biomol Struct Dyn. 2022 01; 40(1):249-262. PMID: 32838660.
      Citations: 12     Fields:    Translation:HumansCells
    9. Kumar S, Sharma PP, Shankar U, Kumar D, Joshi SK, Pena L, Durvasula R, Kumar A, Kempaiah P, Rathi B. Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies. J Chem Inf Model. 2020 12 28; 60(12):5754-5770. PMID: 32551639.
      Citations: 21     Fields:    Translation:HumansCells